Skip to main content
. 2022 May 11;14:100284. doi: 10.1016/j.mtbio.2022.100284

Fig. 4.

Fig. 4

The improved immuno-microenvironment and systemic immunity induced by pep-PAMP@PTX. (a) Schematic of the development of tumor model and experiment design. (b,c) Flow cytometry analysis of in vivo lymphocytic infiltration in resected tumors; (b) the contour diagrams and (c) quantification. (d,e) The serum (d) IFN-γ and (e) IL-2 levels of mice determined on day 18.